View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. Combino Pharm Malta
2 October 2012

Combino Pharm Presents Tobramycin for Inhalation: a New Business Opportunity

Combino Pharm presents a new business opportunity with the product Tobramycin for inhalation.

Product description: Tobramycin Solution for inhalation.

Reference product: Tobi® (Novartis).

Therapeutical indication: Management of cystic fibrosis patients with P. aeruginosa.

Presentation: Ampoule blow-fill-seal 300mg/5ml.

Highlights:

  • Dossier available for submission
  • Alternative formulation

Patent status – EU: Ready to be launched/commercialised/marketed.

Regulatory Details:

  • The product is produced in a EU manufacturing site
  • The dossier has been approved in the EU and CCP is available from PT and ES

Regulatory strategy: Dossier completed with granted MAs in PT and ES through DCP.

Combino Pharm: Alcoholic Clorhexidine Coloured and Aqueous Clorhexidine Transparent
NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. A weekly roundup of the latest news and analysis, sent every Friday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Pharmaceutical Technology